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Materials and Methods  
Unless otherwise stated, reactions were performed in flame-dried glassware under an argon or 
nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried by passage through 
an activated alumina column under argon. 1  Reaction progress was monitored by thin-layer 
chromatography (TLC) or Agilent 1290 UHPLC-MS.  TLC was performed using E. Merck silica 
gel 60 F254 precoated glass plates (0.25 mm) and visualized by UV fluorescence quenching, p-
anisaldehyde, or KMnO4 staining.  Silicycle SiliaFlash® P60 Academic Silica gel (particle size 
40–63 nm) was used for flash chromatography. The (Z)-enol carbonates were purified by 
preparative LC on a Teledyne Isco ACCQPrep HP125; column: C–18, 100 Å, 5 µm, ID 20 mm. 
1H NMR spectra were recorded on Varian Inova 500 MHz and Bruker 400 MHz spectrometers 
and are reported relative to residual CHCl3 (δ 7.26 ppm).  13C NMR spectra were recorded on a 
Varian Inova 500 MHz spectrometer (125 MHz) and Bruker 400 MHz spectrometers (100 MHz) 
and are reported relative to CHCl3 (δ 77.16 ppm). Data for 1H NMR are reported as follows: 
chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration).  Multiplicities are 
reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, 
m = multiplet, br s = broad singlet, br d = broad doublet.  Data for 13C NMR are reported in 
terms of chemical shifts (δ ppm).  IR spectra were obtained by use of a Perkin Elmer Spectrum 
BXII spectrometer or Nicolet 6700 FTIR spectrometer using thin films deposited on NaCl plates 
and reported in frequency of absorption (cm–1).  Optical rotations were measured with a Jasco P-
2000 polarimeter operating on the sodium D-line (589 nm), using a 100 mm path-length cell.  
High resolution mass spectra (HRMS) were obtained from Agilent 6200 Series TOF with an 
Agilent G1978A Multimode source in electrospray ionization (ESI+), atmospheric pressure 
chemical ionization (APCI+), or mixed ionization mode (MM: ESI-APCI+). Reagents were 
purchased from commercial sources and used as received unless otherwise stated.  
List of Abbreviations: 
TLC – thin-layer chromatography 
alloCl – allyl chloroformate 
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General Procedure for Pd-catalyzed Dehydrogenation Reactions 
 
In a nitrogen-filled glovebox, a solution of Pd2(dba)3 (1.8 mg/mL) and (S)-F13-t-BuPHOX (2.8 
mg/mL) in toluene was stirred for 30 min at 25 °C, then 0.5 mL of the resulting catalyst solution 
was added to a one dram vial containing allyl enol carbonate substrate (0.2 mmol) dissolved in 
hexanes (1.5 mL).  The vial was sealed with a Teflon-lined cap, removed from the glovebox, and 
stirred at 25 °C for 16 h unless noted otherwise.  The crude reaction mixture was concentrated 
then purified by silica gel flash chromatography to provide the desired dehydrogenation product. 
 
 
(E)-1-(1H-indol-1-yl)-2-phenylbut-2-en-1-one (3a) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (52.1 mg, 
0.199 mmol, >99% yield, 10:1 E/Z); 1H NMR (400 MHz, CDCl3) δ 8.47 (dq, J = 8.3, 0.9 Hz, 
1H), 7.54 (dq, J = 7.6, 0.8 Hz, 1H), 7.43–7.27 (m, 8H), 6.50 (dd, J = 3.8, 0.7 Hz, 1H), 6.46 (q, J 
= 7.2 Hz, 1H), 1.99 (d, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 169.2, 138.0, 136.0, 
134.9, 134.6, 130.8, 129.1, 128.8, 128.2, 127.2, 125.6, 125.0, 123.9, 120.9, 116.7, 108.5, 15.3; 
IR (Neat Film, NaCl) 3054, 2918, 2854, 1682, 1585, 1535, 1495, 1472, 1451, 1385, 1359, 1331, 
1240, 1204, 1158, 1144, 1079, 1016, 946, 881, 815, 752, 703 cm–1; HRMS (MM:ESI-APCI+) 
m/z calc’d for C18H16NO [M+H]+: 262.1226, found 262.1222. 
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1-(1H-indol-1-yl)-2-phenylprop-2-en-1-one (3b) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (41.4 mg, 
0.167 mmol, 84% yield);1H NMR (400 MHz, CDCl3) δ 8.57–8.54 (m, 1H), 7.57 (dt, J = 7.7, 1.0 
Hz, 1H), 7.51–7.45 (m, 2H), 7.43–7.28 (m, 6H), 6.54 (d, J = 3.7 Hz, 1H), 6.08 (s, 1H), 5.70 (s, 
1H); 13C NMR (100 MHz, CDCl3) δ 168.7, 144.5, 135.7, 135.4, 131.0, 129.2, 129.2, 127.1, 
126.2, 125.3, 124.3, 121.0, 118.6, 116.8, 109.3;	 IR (Neat Film, NaCl) 3055, 2926, 1692, 1535, 
1496, 1471, 1450, 1378, 1348, 1293, 1205, 1156, 1072, 1016, 931, 880, 752, 696 cm–1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C17H14NO [M+H]+: 248.1070, found 248.1063. 
 
 
(E)-1-(1H-indol-1-yl)-2-phenylhept-2-en-1-one (3c) 
Purified by column chromatography (3% Et2O in hexanes) to provide a colorless oil (58.9 mg, 
0.194 mmol, 97% yield, 14:1 E/Z); 1H NMR (400 MHz, CDCl3) δ 8.47 (d, J = 8.3 Hz, 1H), 7.54 
(dd, J = 7.5, 0.9 Hz, 1H), 7.42 – 7.26 (m, 7H), 6.57–6.48 (m, 2H), 6.33 (t, J = 7.5 Hz, 1H), 2.36 
(q, J = 7.5 Hz, 2H), 1.50 (tt, J = 8.2, 6.9 Hz, 2H), 1.37 (dq, J = 14.4, 7.2 Hz, 2H), 0.89 (t, J = 7.3 
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 169.2, 140.2, 136.8, 136.0, 135.2, 130.8, 129.0, 128.8, 
128.2, 127.2, 125.0, 123.9, 120.9, 116.7, 108.5, 31.5, 28.9, 22.6, 14.0; IR (Neat Film, NaCl) 
3053, 2957, 2928, 2858, 1688, 1636, 1600, 1585, 1534, 1494, 1472, 1450, 1379, 1333, 1205, 
1157, 1143, 1113, 1078, 1016, 938, 882, 816, 769, 752, 702 cm–1; HRMS (MM:ESI-APCI+) m/z 
calc’d for C21H22NO [M+H]+: 304.1696, found 304.1688. 
 
 
(E)-1-(1H-indol-1-yl)-4-methyl-2-phenylpent-2-en-1-one (3d) 
Purified by column chromatography (3% Et2O in hexanes) to provide a colorless oil (44.3 mg, 
0.153 mmol, 77% yield, >20:1 E/Z); 1H NMR (400 MHz, CDCl3) δ 8.46 (dd, J = 8.3, 1.0 Hz, 
N
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1H), 7.55 (ddd, J = 7.7, 1.3, 0.7 Hz, 1H), 7.42–7.27 (m, 8H), 6.54 (d, J = 3.8 Hz, 1H), 6.10 (d, J 
= 10.5 Hz, 1H), 2.80 (dhept, J = 10.5, 6.6 Hz, 1H), 1.11 (d, J = 6.6 Hz, 6H); 13C NMR (100 
MHz, CDCl3) δ 169.2, 146.6, 136.0, 135.3, 134.5, 130.9, 128.9, 128.8, 128.8, 127.2, 125.0, 
123.9, 120.9, 116.7, 108.5, 28.3, 22.7; IR (Neat Film, NaCl) 3054, 2962, 2868, 1687, 1534, 
1494, 1450, 1377, 1334, 1238, 1201, 1112, 1078, 1017, 882, 795, 769, 752, 698 cm–1; HRMS 
(MM:ESI-APCI+) m/z calc’d for C20H20NO [M+H]+: 290.1539, found 290.1528. 
 
 
(E)-1-(1H-indol-1-yl)-2,3-diphenylprop-2-en-1-one (3e) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (48.3 mg, 
0.149 mmol, 75% yield, 6:1 E/Z); 1H NMR (400 MHz, CDCl3) δ 8.67 (d, J = 8.2 Hz, 1H), 7.70 
(dd, J = 11.3, 7.5 Hz, 2H), 7.65 (d, J = 3.8 Hz, 1H), 7.59–7.44 (m, 7H), 7.44–7.30 (m, 5H), 6.71 
(d, J = 3.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 169.2, 136.4, 136.1, 135.3, 134.6, 130.9, 
130.0, 129.3, 129.2, 128.9, 128.7, 128.5, 127.1, 126.0, 125.1, 124.1, 121.0, 116.8, 108.9.; IR 
(Neat Film, NaCl) 3053, 3026, 2923, 1684, 1535, 1492, 1472, 1450, 1381, 1333, 1235, 1206, 
1155, 1141, 1112, 1077, 1016, 908, 882, 862, 753, 721, 694 cm–1; HRMS (MM:ESI-APCI+) m/z 
calc’d for C23H18NO [M+H]+: 324.1383, found 324.1380. 
 
 
(E)-1-(1H-indol-1-yl)-2-(o-tolyl)but-2-en-1-one (3f) 
Purified by column chromatography (3% Et2O in hexanes) to provide a colorless oil (50.1 mg, 
0.182 mmol, 91% yield, 12:1 E/Z); 1H NMR (400 MHz, CDCl3) δ 8.40 (d, J = 8.2 Hz, 1H), 7.46 
(dd, J = 7.7, 1.1 Hz, 1H), 7.31–7.26 (m, 1H), 7.25 (d, J = 3.8 Hz, 1H), 7.22–7.16 (m, 3H), 7.12 
(d, J = 7.9 Hz, 2H), 6.42 (d, J = 3.8 Hz, 1H), 6.35 (q, J = 7.2 Hz, 1H), 2.28 (s, 3H), 1.91 (d, J = 
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 169.4, 138.0, 137.9, 135.9, 134.0, 131.9, 130.8, 
129.7, 129.5, 128.9, 127.2, 125.5, 124.9, 123.9, 120.8, 116.7, 108.4, 21.4, 15.3; IR (Neat Film, 
NaCl) 3027, 2919, 2856, 1688, 1533, 1513, 1472, 1450, 1384, 1329, 1239, 1206, 1157, 1143, 
N
O
Ph
N
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1113, 1080, 1017, 946, 882, 828, 770, 753, 723 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C19H18NO [M+H]+: 276.1383, found 276.1375. 
 
 
(E)-1-(1H-indol-1-yl)-2-(4-methoxyphenyl)but-2-en-1-one (3g) 
Purified by column chromatography (8% Et2O in hexanes) to provide a colorless oil (55.0 mg, 
0.189 mmol, 94% yield, 19:1 E/Z);	1H NMR (400 MHz, CDCl3) δ 8.48 (d, J = 8.3 Hz, 1H), 7.54 
(d, J = 7.7 Hz, 1H), 7.41–7.24 (m, 5H), 6.96–6.87 (m, 2H), 6.50 (d, J = 3.8 Hz, 1H), 6.40 (q, J = 
7.1 Hz, 1H), 3.81 (s, 3H), 1.99 (d, J = 7.1 Hz, 3H).;13C NMR (100 MHz, CDCl3) δ 169.6, 159.4, 
137.6, 135.9, 133.6, 130.8, 130.3, 127.3, 127.2, 124.9, 123.9, 120.8, 116.7, 114.2, 108.4, 55.4, 
15.3; IR (Neat Film, NaCl) 2934, 2361, 1684, 1607, 1511, 1450, 1328, 1292, 1250, 1202, 1178, 
1110, 1079, 1032, 948, 881, 838, 815, 770, 753 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C19H18NO2 [M+H]+: 292.1332, found 292.1340. 
 
 
 (E)-2-(4-fluorophenyl)-1-(1H-indol-1-yl)but-2-en-1-one (3h) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (49.8 mg, 
0.178 mmol, 89% yield, 13:1 E/Z); 1H NMR (400 MHz, CDCl3) δ 8.45 (d, J = 8.2 Hz, 1H), 7.55 
(dt, J = 7.7, 0.9 Hz, 1H), 7.40–7.32 (m, 4H), 7.32–7.26 (m, 1H), 7.13–7.06 (m, 2H), 6.53 (d, J = 
3.8 Hz, 1H), 6.45 (q, J = 7.1 Hz, 1H), 1.96 (d, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
169.0, 162.45 (d, JC–F = 248.2 Hz), 136.9, 135.9, 134.9, 130.9, 130.8, 127.0, 125.1, 124.0, 120.9, 
116.6, 116.0, 115.7, 108.7, 15.2; 19F NMR (282 MHz, CDCl3) δ –113.18 (dtq, J = 10.8, 5.3, 2.3 
Hz). IR (Neat Film, NaCl) 3051, 2917, 1685, 1602, 1534, 1509, 1472, 1450, 1385, 1331, 1224, 
1202, 1160, 1101, 1080, 1016, 948, 881, 842, 786, 770, 754 cm–1; HRMS (MM:ESI-APCI+) m/z 
calc’d for C18H15FNO [M+H]+: 280.1132, found 280.1137.	 
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(E)-2-(4-chlorophenyl)-1-(1H-indol-1-yl)but-2-en-1-one (3i) 
Purified by column chromatography (5% Et2O in hexanes) to provide a colorless oil (46.7 mg, 
0.158 mmol, 79% yield, 8:1 E/Z); 1H NMR (400 MHz, CDCl3) δ 8.45 (d, J = 8.1 Hz, 1H), 7.59–
7.51 (m, 1H), 7.40–7.26 (m, 7H), 6.53 (d, J = 3.7 Hz, 1H), 6.46 (q, J = 7.2 Hz, 1H), 1.97 (d, J = 
7.1 Hz, 3H);	 13C NMR (100 MHz, CDCl3) δ 168.7, 136.9, 135.9, 135.3, 134.2, 133.2, 130.4, 
129.2, 129.0, 127.0, 125.1, 124.1, 120.9, 116.6, 108.8, 15.3; IR (Neat Film, NaCl) 3051, 2916, 
1688, 1534, 1491, 1472, 1451, 1384, 1330, 1204, 1143, 1089, 1016, 947, 881, 838, 802, 770, 754 
cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C18H15ClNO [M+H]+: 296.0837, found 296.0835. 
 
Enolization of N-Acyl Indole Substrates 
 
(E)-1-(1H-indol-1-yl)-2-phenylbut-1-en-1-yl allyl carbonate ((E)-1) 
To a flame-dried flask was added LHMDS (2.68 g, 16.0 mmol) followed by toluene (24.0 mL) 
and N,N-dimethylethylamine (1.7 mL, 16.0 mmol, 2.0 equiv), and the resulting mixture stirred at 
25 °C for 5 min.  A solution of SI1 (2.11 g, 8.00 mmol, 1.0 equiv) in toluene (16.0 mL) was then 
added, and the reaction stirred at 25 °C for an additional 2 hours.  The flask was then submerged 
in a room temperature water bath, and allyl chloroformate (1.7 mL, 16 mmol, 2.0 equiv) was 
added neat, and the reaction continued until no starting material remained by TLC (typically less 
than 30 min).  The crude reaction mixture was diluted with Et2O and quenched with water.  The 
layers were separated, and the aqueous layer was extracted with Et2O twice.  The combined 
organic layers were dried over Na2SO4 and concentrated. Purified by column chromatography 
(5% Et2O in hexanes) to provide (E)-1 as a colorless oil (>98:2 E/Z, 2.08 g, 75% yield); 1H NMR 
(500 MHz, CDCl3) δ 7.55–7.43 (m, 2H), 7.24–7.18 (m, 1H), 7.15–7.06 (m, 4H), 7.02–6.94 (m, 
2H), 6.89 (d, J = 3.3 Hz, 1H), 6.35 (dd, J = 0.9, 3.4 Hz, 1H), 5.88 (ddt, J = 5.8, 10.4, 17.1 Hz, 
1H), 5.37–5.23 (m, 2H), 4.61 (dt, J = 1.4, 5.8 Hz, 2H), 2.68 (q, J = 7.5 Hz, 2H), 1.09 (t, J = 7.5 
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 152.7, 136.2, 135.0, 130.8, 130.2, 129.0, 128.4, 128.2, 
N
O
Me
Cl
N
O
Ph
Et
Me2NEt
LHMDS
toluene, 25 ºC
then alloCl, 0 to 25 ºC
N
OCO2allyl
Et
Ph
(E)-1SI1
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127.5, 127.5, 122.6, 120.7, 119.4, 111.2, 103.9, 69.3, 24.9, 12.6; IR (Neat Film, NaCl) 3056, 
2974, 1766, 1682, 1519, 1456, 1333, 1259, 1238, 1209, 1143, 1119, 1094, 1042, 968, 946, 913, 
765, 743, 699 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C22H22NO3 [M+H]+: 348.1594, 
found 348.1588. 
 
General Procedure for the Enolization of N-Acyl Indole Substrates 
 
To a flame-dried flask was added KHMDS (2.0 equiv) followed by THF (0.20 M) and the 
resulting mixture stirred at 0 °C for 5 min.  A solution of N-acyl indole (1.0 equiv) in THF (0.50 
M) was then added dropwise, and the reaction stirred at 0 °C for 10 min then at 20 ºC for 3 h.  
The flask was then submerged in a room temperature water bath, and allyl chloroformate (2.0 
equiv) was added neat, and the reaction continued until no starting material remained by TLC 
(typically less than 30 min).  The crude reaction mixture was diluted with Et2O and quenched 
with water.  The layers were separated, and the aqueous layer was extracted with Et2O twice.  
The combined organic layers were dried over Na2SO4 and concentrated.  The (Z)-enol carbonates 
were purified by preparative LC on a Teledyne Isco ACCQPrep HP125; column: C–18, 100 Å, 5 
µm, ID 20 mm, gradient 50 to 100% MeCN/H2O (0.25% AcOH). 
 
(Z)-1-(1H-indol-1-yl)-2-phenylbut-1-en-1-yl allyl carbonate ((Z)-1) 
Isolated as a viscous, colorless oil (168.2 mg, 0.484 mmol, 48% yield); 1H NMR (400 MHz, 
CDCl3) δ 7.63 (d, J = 0.9 Hz, 1H), 7.57–7.53 (m, 1H), 7.46–7.38 (m, 4H), 7.34 (dd, J = 8.5, 2.9 
Hz, 2H), 7.31–7.27 (m, 1H), 7.19 (t, J = 7.5 Hz, 1H), 6.62 (d, J = 3.2 Hz, 1H), 5.68 (ddt, J = 
17.1, 10.6, 5.6 Hz, 1H), 5.18–5.02 (m, 2H), 4.43 (dt, J = 5.6, 1.4 Hz, 2H), 2.20 (q, J = 7.5 Hz, 
2H), 0.85 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 152.9, 136.7, 136.2, 133.7, 132.6, 
130.8, 128.8, 128.5, 128.5, 128.1, 127.9, 122.9, 121.0, 118.8, 111.1, 104.0, 69.0, 25.4, 12.7; IR 
N
O
Ar
R
KHMDS (2.0 equiv)
THF, 0 to 25 ºC
then alloCl, 0 to 25 ºC
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(Neat Film, NaCl) 3054, 2972, 2356, 1761, 1684, 1518, 1456, 1331, 1296, 1241, 1211, 1140, 
1117, 1038, 961, 824, 765, 744, 702 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C22H22NO3 
[M+H]+: 348.1594, found 348.1586. 
 
 
 
 
(Z)-1-(1H-indol-1-yl)-2-phenylprop-1-en-1-yl allyl carbonate (1b) 
Isolated as a viscous, colorless oil (145.4 mg, 0.436 mmol, 44% yield); 1H NMR (400 MHz, 
CDCl3) δ 7.65 (dt, J = 7.8, 0.8 Hz, 1H), 7.56–7.48 (m, 1H), 7.51–7.43 (m, 2H), 7.46–7.36 (m, 
2H), 7.40–7.30 (m, 2H), 7.29 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.24–7.15 (m, 1H), 6.64 (d, J = 3.1 
Hz, 1H), 5.80–5.57 (m, 1H), 5.20–5.04 (m, 2H), 4.46 (dt, J = 5.6, 1.4 Hz, 2H), 1.88 (s, 3H); 13C 
NMR (100 MHz, CDCl3) δ 152.8, 137.8, 136.4, 134.1, 130.8, 128.6, 128.4, 128.2, 128.0, 127.7, 
125.5, 122.9, 121.0, 121.0, 118.9, 111.3, 104.3, 69.1, 18.8; IR (Neat Film, NaCl) 3055, 1763, 
1684, 1518, 1474, 1456, 1328, 1295, 1278, 1242, 1213, 1141, 1118, 1078, 1027, 950, 764, 744, 
700 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C21H20NO3 [M+H]+: 334.1438, found 
334.1447. 
 
 
(Z)-1-(1H-indol-1-yl)-2-phenylhept-1-en-1-yl allyl carbonate (1c) 
Isolated as a viscous, colorless oil (152.7 mg, 0.436 mmol, 44% yield); 1H NMR (400 MHz, 
CDCl3) δ 7.64 (dt, J = 7.8, 0.7 Hz, 1H), 7.54 (dq, J = 8.1, 0.7 Hz, 1H), 7.40 (d, J = 3.5 Hz, 4H), 
7.34 (p, J = 4.0 Hz, 2H), 7.30–7.25 (m, 1H), 7.19 (ddd, J = 8.0, 7.3, 1.1 Hz, 1H), 6.62 (d, J = 3.2 
Hz, 1H), 5.68 (ddt, J = 17.2, 10.7, 5.6 Hz, 1H), 5.20–4.98 (m, 2H), 4.43 (dt, J = 5.6, 1.5 Hz, 2H), 
2.26–2.08 (m, 2H), 1.21 (ddt, J = 12.6, 8.9, 4.6 Hz, 2H), 1.14–0.97 (m, 4H), 0.78–0.63 (m, 3H); 
13C NMR (100 MHz, CDCl3) δ 152.9, 136.7, 136.5, 134.1, 131.5, 130.9, 129.0, 128.5, 128.5, 
N
O
Me
O
O
N
O
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128.1, 127.9, 122.8, 121.0, 118.9, 111.2, 104.0, 69.0, 32.0, 31.3, 27.3, 22.3, 13.9; IR (Neat Film, 
NaCl) 3055, 2955, 2928, 1762, 1682, 1518, 1456, 1326, 1296, 1242, 1212, 1140, 1120, 988, 952, 
765, 743, 718, 699 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C25H28NO3 [M+H]+: 
390.2064, found 390.2060. 
 
 
(Z)-1-(1H-indol-1-yl)-4-methyl-2-phenylpent-1-en-1-yl allyl carbonate (1d) 
Isolated as a viscous, colorless oil (137.2 mg, 0.365 mmol, 37% yield); 1H NMR (400 MHz, 
CDCl3) δ 7.64 (d, J = 7.8 Hz, 1H), 7.53 (d, J = 8.1 Hz, 1H), 7.45–7.38 (m, 4H), 7.38–7.31 (m, 
2H), 7.31–7.26 (m, 1H), 7.19 (t, J = 7.5 Hz, 1H), 6.62 (d, J = 3.3 Hz, 1H), 5.78–5.47 (m, 1H), 
5.18–4.97 (m, 2H), 4.42 (dt, J = 5.5, 1.3 Hz, 2H), 2.08 (d, J = 7.3 Hz, 2H), 1.42 (dh, J = 13.7, 6.8 
Hz, 1H), 0.73 (d, J = 6.6 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 152.8, 135.9, 135.8, 135.7, 
135.6, 130.9, 130.2, 129.7, 129.0, 128.9, 128.4, 127.6, 125.5, 122.5, 120.8, 120.7, 119.6, 111.4, 
103.4, 69.5, 25.5, 19.7, 12.1; IR (Neat Film, NaCl) 3057, 3030, 2956, 1766, 1682, 1611, 1518, 
1456, 1384, 1366, 1347, 1326, 1296, 1278, 1244, 1210, 1140, 1117, 1066, 971, 946, 888, 766, 
743, 718, 700 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C24H26NO3 [M+H]+: 376.1907, 
found 376.1910. 
 
 
(Z)-1-(1H-indol-1-yl)-2,3-diphenylprop-1-en-1-yl allyl carbonate (1e) 
Isolated as a viscous, colorless oil (129.2 mg, 0.316 mmol, 32% yield); 1H NMR (400 MHz, 
CDCl3) δ 7.64 (dt, J = 7.8, 1.0 Hz, 1H), 7.63–7.55 (m, 1H), 7.38 (d, J = 3.4 Hz, 1H), 7.33–7.27 
(m, 6H), 7.21 (ddd, J = 8.1, 7.1, 1.1 Hz, 1H), 7.16–7.08 (m, 3H), 6.95–6.87 (m, 2H), 6.67–6.53 
(m, 1H), 5.68 (ddt, J = 17.3, 10.6, 5.6 Hz, 1H), 5.17–5.02 (m, 2H), 4.45 (dt, J = 5.6, 1.4 Hz, 2H), 
3.55 (s, 2H);	13C NMR (100 MHz, CDCl3) δ 152.8, 137.6, 136.7, 136.2, 135.4, 130.8, 129.6, 
N
O
i-Bu
O
O
N
O
Bn
O
O
Supporting Information for Fulton, Wu, Alexy, Zhang, and Stoltz 	
 
S11 
128.8, 128.6, 128.4, 128.4, 128.0, 126.4, 123.0, 121.2, 121.1, 119.0, 111.2, 104.4, 69.1, 38.3; IR 
(Neat Film, NaCl) 3060, 3027, 1763, 1683, 1518, 1494, 1474, 1456, 1328, 1294, 1278, 1242, 
1214, 1139, 1113, 1068, 987, 939, 766, 744, 712, 700 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d 
for C27H24NO3 [M+H]+: 410.1751, found 410.1732. 
 
 
(Z)-1-(1H-indol-1-yl)-2-(o-tolyl)but-1-en-1-yl allyl carbonate (1f) 
Isolated as a viscous, colorless oil (117.4 mg, 0.324 mmol, 32% yield); 1H NMR (400 MHz, 
CDCl3) δ 7.56 (dq, J = 8.1, 0.7 Hz, 1H), 7.51–7.44 (m, 1H), 7.22 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 
7.14–7.08 (m, 1H), 7.08–6.97 (m, 4H), 6.85 (d, J = 3.3 Hz, 1H), 6.27 (d, J = 3.3 Hz, 1H), 5.90 
(ddt, J = 17.3, 10.4, 5.8 Hz, 1H), 5.42–5.13 (m, 2H), 4.69–4.57 (m, 2H), 2.60 (ddt, J = 59.4, 
13.8, 6.9 Hz, 2H), 2.17 (s, 3H), 1.09 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 152.8, 
136.8, 136.5, 134.6, 131.1, 130.9, 129.1, 128.5, 128.5, 128.4, 128.2 (overlapping), 127.9, 122.8, 
121.0, 118.8, 111.3, 104.0, 69.0, 40.8, 25.9, 22.3;	 IR (Neat Film, NaCl) 2934, 2361, 1684, 1607, 
1511, 1450, 1328, 1292, 1250, 1202, 1178, 1110, 1079, 1032, 948, 881, 838, 815, 770, 753 cm–1; 
HRMS (MM:ESI-APCI+) m/z calc’d for C23H24NO3 [M+H]+: 362.1751, found 362.1749. 
 
 
(Z)-1-(1H-indol-1-yl)-2-(4-methoxyphenyl)but-1-en-1-yl allyl carbonate (1g) 
Isolated as a viscous, colorless oil (168.6 mg, 0.447 mmol, 45% yield); 1H NMR (400 MHz, 
CDCl3) δ 7.63 (dt, J = 7.8, 1.0 Hz, 1H), 7.55–7.51 (m, 1H), 7.37–7.30 (m, 3H), 7.30–7.24 (m, 
1H), 7.21–7.14 (m, 1H), 6.98–6.91 (m, 2H), 6.61 (dd, J = 3.3, 1.0 Hz, 1H), 5.82–5.57 (m, 1H), 
5.21–5.02 (m, 2H), 4.45 (dt, J = 5.6, 1.4 Hz, 2H), 3.85 (s, 3H), 2.17 (q, J = 7.5 Hz, 2H), 0.84 (t, J 
= 7.5 Hz, 3H);13C NMR (100 MHz, CDCl3) δ 159.3, 152.9, 136.7, 133.5, 132.2, 130.9, 129.4, 
128.9, 128.4, 128.3, 122.8, 121.0, 120.9, 118.9, 113.9, 111.2, 103.9, 69.0, 55.3, 25.4, 12.9; IR 
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(Neat Film, NaCl) 2972, 1765, 1687, 1519, 1456, 1333, 1259, 1238, 1210, 1144, 1115, 1088, 
1039, 969, 945, 763, 743 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for C23H24NO4 [M+H]+: 
378.1700, found 378.1713. 
 
 
(Z)-allyl (2-(4-fluorophenyl)-1-(1H-indol-1-yl)but-1-en-1-yl) carbonate (1h) 
Isolated as a viscous, colorless oil (225.1 mg, 0.616 mmol, 31% yield); 1H NMR (400 MHz, 
CDCl3) δ 7.66 (dt, J = 7.8, 1.0 Hz, 1H), 7.55 (ddd, J = 8.2, 1.7, 0.6 Hz, 1H), 7.44–7.37 (m, 2H), 
7.34 (d, J = 3.3 Hz, 1H), 7.33–7.29 (m, 1H), 7.22 (ddd, J = 8.0, 7.1, 1.1 Hz, 1H), 7.17–7.10 (m, 
2H), 6.65 (dd, J = 3.2, 0.8 Hz, 1H), 5.72 (ddt, J = 17.2, 10.5, 5.7 Hz, 1H), 5.24–5.08 (m, 2H), 
4.46 (dt, J = 5.7, 1.4 Hz, 2H), 2.21 (q, J = 7.5 Hz, 2H), 0.86 (t, J = 7.5 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 162.41 (d, JC–F = 246.9 Hz), 152.8, 136.7, 134.1, 132.1 (d, JC–F = 3.5 Hz), 131.6, 
130.8, 130.0 (d, JC–F = 8.2 Hz), 128.7, 128.5, 122.9, 121.0, 119.1, 115.7, 115.5, 111.1, 104.2, 
69.1, 25.5, 12.7;19F NMR (282 MHz, CDCl3) δ –113.98 – –114.11 (m);.IR (Neat Film, NaCl) 
3052, 2973, 1763, 1685, 1604, 1510, 1456, 1331, 1296, 1242, 1211, 1160, 1140, 1117, 1066, 
1037, 1012, 960, 846, 767, 745 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for C22H21FNO3 
[M+H]+: 366.1500, found 366.1496.	 
 
 
(Z)-allyl (2-(4-chlorophenyl)-1-(1H-indol-1-yl)but-1-en-1-yl) carbonate (1i) 
1H NMR (400 MHz, CDCl3) δ 7.65 (dt, J = 7.8, 0.9 Hz, 1H), 7.57–7.50 (m, 1H), 7.43–7.34 (m, 
4H), 7.32 (d, J = 3.3 Hz, 1H), 7.34–7.25 (m, 1H), 7.20 (td, J = 7.5, 7.1, 1.0 Hz, 1H),	 6.64 (d, J = 
3.2 Hz, 1H), 5.71 (ddt, J = 17.1, 10.5, 5.7 Hz, 1H), 5.21–5.08 (m, 2H), 4.45 (dt, J = 5.7, 1.5 Hz, 
2H), 2.20 (q, J = 7.5 Hz, 2H), 0.85 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 152.7, 
136.6, 134.7, 134.2, 133.9, 131.3, 130.7, 129.6, 128.8, 128.7, 128.5, 123.0, 121.1, 121.1, 119.2, 
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111.1, 104.3, 69.2, 25.3, 12.7; IR (Neat Film, NaCl) 2972, 1762, 1681, 1491, 1474, 1455, 1241, 
1209, 1140, 1111, 1014, 960, 816, 765, 744 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C22H21ClNO [M+H]+: 382.1204, found 382.1189. 
 
Preparation of N-Acyl Indoles 
 
General Procedure 1 
 
 
To an oven-dried vial containing α-aryl carboxylic acid (1.2 equiv) was added SOCl2 neat 
(2.4 equiv) and the resuting mixture stirred at 25 °C for 20 min then 70 °: effluent gas flow is 
bubbled through a glass tube packed with powdered NaOH).  The reaction was then concentrated 
in vacuo to afford the crude acid chloride, which was used in the next step without further 
purification. 
A flame-dried flask containing indole (1.0 equiv) in THF (500 mM) was cooled to 0 °C 
in an ice bath and n-BuLi (1.05 equiv) was added dropwise.  The mixture was stirred at 0 °C for 
15 min then cooled to –78 °C in a dry-ice acetone bath.  The crude acid chloride dissolved in 
THF is then added quickly, and the resulting mixture allowed to slowly warm to room 
temperature.  Then reaction was then quenched with water and extracted with Et2O.  The 
combined organic layers were dried over Na2SO4 and the desired N-acyl indole isolated by silica 
gel flash chromatography. 
 
 
1-(1H-indol-1-yl)-2-phenylbutan-1-one (SI1) 
Prepared according to general procedure 1.  Purified by column chromatography (3% Et2O in 
hexanes) to provide the desired product as a white solid (428.2 mg, 81% yield); 1H NMR (300 
MHz, CDCl3): δ 8.54 (d, J = 8.3, 1H), 7.51–7.42 (m, 2H), 7.38–7.13 (m, 7H), 6.48 (d, J = 3.8 
Hz, 1H), 4.10 (t, J = 7.2 Hz, 1H), 2.35–2.18 (m, 1H), 1.89 (dt, J = 13.7, 7.2 Hz, 1H), 0.93 (t, J = 
7.4 Hz, 3H); 13C NMR (CDCl3, 100 MHz): δ 171.9, 139.1, 136.0, 130.3, 129.1, 127.7, 127.5, 
125.2, 124.9, 123.8, 120.8, 117.0, 109.1, 53.7, 27.9, 12.3;  IR (Neat Film, NaCl) 3063, 2967, 
N
O
Et
HO
O
R
Ar
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R
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2943, 2874, 1704, 1602, 1584, 1539, 1472, 1451, 1384, 1355, 1328, 1304, 1222, 1208, 1181, 
1154, 1082, 1017, 903, 880, 825, 807, 766, 749, 700 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d 
for C18H18NO [M+H]+: 264.1383, found 264.1377. 
 
 
1-(1H-indol-1-yl)-2-(4-methoxyphenyl)butan-1-one (SI2) 
Prepared according to general procedure 1. Purified by column chromatography (3% Et2O in 
hexanes) to provide the desired product as a yellow oil containing minor impurities (1.2439 g, 
85% yield); 1H NMR (500 MHz, CDCl3) δ 8.56 (dq, J = 8.3, 0.9 Hz, 1H), 7.53–7.48 (m, 2H), 
7.35 (ddd, J = 8.4, 7.2, 1.3 Hz, 1H), 7.30–7.22 (m, 3H), 6.89–6.82 (m, 2H), 6.53 (dd, J = 3.8, 0.7 
Hz, 1H), 4.10 (t, J = 7.3 Hz, 1H), 3.76 (s, 3H), 2.37–2.20 (m, 1H), 1.90 (m, 1H), 0.97 (t, J = 7.3 
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 172.2, 158.9, 135.9, 131.1, 130.3, 128.7, 125.1, 124.9, 
123.7, 120.7, 116.9, 114.4, 108.9, 55.1, 52.8, 27.8, 12.2; IR (Neat Film, NaCl) 2964, 2933, 1702, 
1610, 1540, 1511, 1450, 1384, 1354, 1324, 1302, 1252, 1222, 1207, 1179, 1154, 1033, 904, 820, 
788, 766, 752 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for C19H20NO2 [M+H]+: 294.1489, 
found 294.1494. 
 
General Procedure 2 
 
A flame-dried round bottom flask was charged with i-Pr2NH (367 µL, 2.60 mmol, 1.3 
equiv) and THF (18.0 mL). The solution was then cooled in a 0 ºC ice bath for 10 min and a 2.40 
M solution of n-BuLi (996 µL, 2.40 mmol, 1.2 equiv) was added dropwise. After stirring for 15 
min, the solution was cooled in a –78 ºC acetone/dry ice bath for 15 min, after which time a 
solution of acyl indole (498.6 mg, 2.00 mmol, 1.0 equiv) in THF (4.0 mL) was added dropwise 
over 5 min. After stirring at –78 ºC for 1 h, neat ethyl iodide (193 µL, 2.40 mmol, 1.2 equiv) was 
then added dropwise. The reaction mixture was allowed to slowly warm to 20 ºC, and then 
heated to 65 ºC and stirred for 16 h, after which time the reaction was quenched with the slow 
addition of 10 mL H2O. The mixture was then transferred to a separatory funnel and the layers 
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were separated. The aqueous layer was extracted 3 x 10 mL Et2O and the combined organics 
were dried over Na2SO4, filtered, and concentrated. The desired N-acyl indole was isolated by 
silica gel flash chromatography. 
 
 
1-(1H-indol-1-yl)-2-(o-tolyl)butan-1-one (SI3) 
Prepared according to General Procedure 2 with (623.3 mg, 2.50 mmol, 1.0 equiv) of acyl 
indole. Purified by column chromatography (5% Et2O in hexanes) to provide the desired product 
as an amorphous white solid (458.8 mg, 66% yield); 1H NMR (400 MHz, CDCl3) δ 8.60 (d, J = 
8.3 Hz, 1H), 7.50 (dt, J = 7.7, 1.0 Hz, 1H), 7.36 (ddd, J = 8.5, 7.2, 1.3 Hz, 1H), 7.29–7.21 (m, 
3H), 7.19 (d, J = 3.8 Hz, 1H), 7.13 (pd, J = 7.3, 1.8 Hz, 2H), 6.48 (d, J = 3.7 Hz, 1H), 4.34 (dd, J 
= 8.5, 5.4 Hz, 1H), 2.51 (s, 3H), 2.30 (ddq, J = 14.4, 8.7, 7.4 Hz, 1H), 1.81 (dqd, J = 14.7, 7.4, 
5.4 Hz, 1H), 1.05 (t, J = 7.4 Hz, 3H);	13C NMR (100 MHz, CDCl3) δ 172.3, 138.1, 136.1, 134.5, 
131.1, 130.3, 127.4, 127.1, 126.9, 125.2, 124.5, 123.8, 120.8, 117.0, 109.2, 49.9, 27.3, 19.8, 
12.9; IR (Neat Film, NaCl) 2966, 2876, 1703, 1539, 1450, 1383, 1354, 1327, 1306, 1222, 1207, 
1156, 1107, 1080, 1017, 903, 830, 750, 712 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C19H20NO [M+H]+: 278.1539, found 278.1547. 
 
 
2-(4-chlorophenyl)-1-(1H-indol-1-yl)butan-1-one (SI4) 
Prepared according to General Procedure 2 with (539.5 mg, 2.00 mmol, 1.0 equiv) of acyl 
indole. Purified by column chromatography (5% Et2O in hexanes) to provide the desired product 
as a light yellow oil (373.8 mg, 63% yield); 1H NMR (500 MHz, CDCl3) δ 8.54 (dd, J = 8.4, 0.9 
Hz, 1H), 7.52 (dt, J = 7.7, 1.1 Hz, 1H), 7.44 (d, J = 3.8 Hz, 1H), 7.36 (ddd, J = 8.4, 7.2, 1.3 Hz, 
1H), 7.30 (s, 4H), 7.28–7.24 (m, 1H), 6.56 (dd, J = 3.9, 0.8 Hz, 1H), 4.13 (t, J = 7.3 Hz, 1H), 
2.29 (dt, J = 13.8, 7.3 Hz, 1H), 2.03–1.76 (m, 1H), 0.97 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 171.5, 137.6, 136.0, 133.5, 130.4, 129.4, 129.2, 125.4, 124.6, 124.0, 120.9, 117.0, 
109.5, 53.1, 27.9, 12.3; IR (Neat Film, NaCl) 2967, 2361, 1700, 1540, 1491, 1451, 1384, 1354, 
N
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1328, 1302, 1221, 1207, 1094, 1015, 904, 814, 794, 752 cm-1; HRMS (MM:ESI-APCI+) m/z 
calc’d for C18H17ClNO [M+H]+: 298.0993, found 298.0984. 	
 
2-(4-fluorophenyl)-1-(1H-indol-1-yl)butan-1-one (SI5) 
Prepared according to General Procedure 2 with (506.6 mg, 2.00 mmol, 1.0 equiv) of acyl 
indole. Purified by column chromatography (5% Et2O in hexanes) to provide the desired product 
as a white solid (360.4 mg, 64% yield); 1H NMR (500 MHz, CDCl3) δ 8.55 (d, J = 8.3 Hz, 1H), 
7.52 (dd, J = 7.7, 1.0 Hz, 1H), 7.46 (d, J = 3.8 Hz, 1H), 7.39–7.29 (m, 3H), 7.30–7.22 (m, 1H), 
7.07–6.97 (m, 2H), 6.56 (dd, J = 3.8, 0.6 Hz, 1H), 4.15 (t, J = 7.3 Hz, 1H), 2.30 (dt, J = 13.8, 7.3 
Hz, 1H), 1.92 (dq, J = 14.1, 7.3 Hz, 1H), 0.98 (t, J = 7.3 Hz, 3H); 19F NMR (282 MHz, CDCl3) δ 
–114.9 (tt, J = 8.5, 5.2 Hz); 13C NMR (100 MHz, CDCl3) δ 171.8, 162.1 (d, JC–F = 246.2 Hz), 
136.0, 134.8 (d, JC–F = 3.3 Hz), 130.3, 129.4 (d, JC–F = 8.0 Hz), 125.3, 124.7, 123.9, 120.9, 117.0, 
116.0 (d, JC–F = 21.5 Hz), 109.3, 52.8, 27.9, 12.2; IR (Neat Film, NaCl) 3074, 2967, 2934, 2873, 
1702, 1603, 1508, 1450, 1384, 1354, 1327, 1301, 1222, 1207, 1158, 818, 792, 752, 714 cm–1; 
HRMS (MM:ESI-APCI+) m/z calc’d for C18H17FNO [M+H]+: 282.1289, found 282.1286. 
 
 
General Procedure 3  
 
 
A flame-dried round bottom flask was charged with i-Pr2NH (1.82 mL, 13.0 mmol, 1.3 
equiv) and THF (15 mL). The solution was then cooled in a 0 ºC ice bath for 10 min and a 2.40 
M solution of n-BuLi (5.0 mL, 12.0 mmol, 1.2 equiv) was added dropwise. After stirring for 15 
min, the solution was cooled in a –78 ºC acetone/dry ice bath for 15 min, after which time a 
solution of methyl phenyl acetate (1.41 mL, 10.0 mmol, 1.0 equiv) in THF (29 mL) was added 
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dropwise over 10 min. After stirring at –78 ºC for 1 h, the appropriate electrophile (1.5 equiv) 
was then added neat dropwise. The reaction mixture was allowed to slowly warm to 20 ºC and 
stirred for 16 h after which time the reaction was quenched with the slow addition of 30 mL of 
sat. aq. NH4Cl. The mixture was then transferred to a separatory funnel and the layers were 
separated. The aqueous layer was extracted 3 x 20 mL EtOAc and the combined organics were 
dried over Na2SO4, filtered, and concentrated.  
 The crude material was then transferred to a round bottom flask and dissolved in THF (28 
mL) and H2O (20 mL). To the solution was then added LiOH (479.0 mg, 20.0 mmol, 2.0 equiv) 
and the resulting reaction mixture was stirred at 20 ºC for 16 h. The mixture was then transferred 
to a separatory funnel and washed with 2 x 5 mL Et2O. The aqueous layer was then slowly 
acidified to pH 1 with 2.0 N HCl and extracted 2 x 10 mL Et2O. The combined organics were 
dried over Na2SO4, filtered, and concentrated. The crude acid was used in the next step without 
further purification.  
To an oven-dried flask containing α-aryl carboxylic acid (5.0 mmol, 1.0 equiv) was 
added SOCl2 neat (620 µL, 1.7 equiv) and the resulting mixture stirred at 25 °C for 20 min then 
70 °C for 2 h (note: effluent gas flow is bubbled through a glass tube packed with powdered 
NaOH). The reaction was then concentrated in vacuo to afford the crude acid chloride, which 
was used in the next step without further purification. 
A separate flame-dried flask containing freshly distilled indoline (4.20 mmol, 1.0 equiv), 
Et3N (1.17 mL, 8.40 mmol, 2.0 equiv), and DMAP (25.7 mg, 0.21 mmol, 0.05 equiv) in CH2Cl2 
(42 mL) was cooled to –10 °C in an acetone/ice bath and the crude acid chloride (5.0 mmol, 1.2 
equiv) dissolved in CH2Cl2 (21 mL) was added dropwise via cannula transfer.  The mixture was 
stirred at –10 °C for 15 min then warmed to 23 ºC and stirred for 18 h.  The reaction mixture was 
quenched with saturated NaHCO3 (20 mL) and transferred to a separatory funnel. The layers 
were separated and the aqueous layer was extracted twice with CH2Cl2 (20 mL). The combined 
organics were washed with brine (10 mL), dried over Na2SO4, filtered, and concentrated to 
afford the crude amide which was used in the next step without further purification. 
The crude amide prepared above was transferred to a round bottom flask affixed with a 
reflux condenser.  Dry toluene (42 mL) and DDQ (2,3-Dichloro-5,6-dicyano-1,4-benzoquinone) 
(1.14 g, 5.0 mmol, 1.2 equiv) were then added and the resulting dark red reaction solution was 
heated to reflux for 16 h. The crude reaction mixture was then filtered through a pad of celite 
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with toluene, concentrated, and purified via flash column chromatography to afford the desired 
acyl indole. 
 
1-(1H-indol-1-yl)-2-phenylheptan-1-one (SI6) 
Prepared according to General Procedure 3 with n-pentyl iodide (1.96 mL, 15.0 mmol, 1.5 
equiv). Purified by column chromatography (5% Et2O in hexanes) to provide the desired product 
as a colorless oil (319.5 mg, 25% yield);	1H NMR (500 MHz, CDCl3) δ 8.58 (dq, J = 8.4, 0.9 Hz, 
1H), 7.54–7.48 (m, 2H), 7.39–7.30 (m, 5H), 7.30–7.21 (m, 2H), 6.54 (dd, J = 3.8, 0.8 Hz, 1H), 
4.25 (t, J = 7.2 Hz, 1H), 2.34–2.25 (m, 1H), 1.90 (tdd, J = 12.9, 8.5, 5.7 Hz, 1H), 1.46–1.25 (m, 
6H), 0.91–0.84 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 172.0, 139.4, 136.0, 130.3, 129.2, 127.7, 
127.5, 125.2, 124.8, 123.8, 120.7, 117.0, 109.1, 52.1, 34.7, 31.8, 27.4, 22.6, 14.1; IR (Neat Film, 
NaCl) 3063, 3029, 2954, 2928, 2858, 1704, 1602, 1584, 1539, 1451, 1384, 1353, 1311, 1207, 
1154, 1102, 941, 919, 880, 766, 749, 700 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C21H24NO [M+H]+: 306.1846, found 306.1846. 
 
	
1-(1H-indol-1-yl)-2,3-diphenylpropan-1-one (SI7) 
Prepared according to General Procedure 3 with BnBr (1.78 mL, 15.0 mmol, 1.5 equiv). Purified 
by column chromatography (5% Et2O in hexanes) to provide the desired product as a white solid 
(830.7 mg, 61% yield); 1H NMR (500 MHz, CDCl3) δ 8.56 (dd, J = 8.3, 0.9 Hz, 1H), 7.48 (dt, J 
= 7.5, 0.9 Hz, 1H), 7.39 (d, J = 3.8 Hz, 1H), 7.34 (ddd, J = 8.4, 7.2, 1.3 Hz, 1H), 7.32–7.27 (m, 
4H), 7.26–7.10 (m, 7H), 6.48 (dd, J = 3.9, 0.7 Hz, 1H), 4.51 (t, J = 7.2 Hz, 1H), 3.67 (dd, J = 
13.7, 7.6 Hz, 1H), 3.14 (dd, J = 13.8, 6.9 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 171.2, 139.1, 
138.7, 136.0, 130.3, 129.3, 129.2, 128.5, 127.8, 127.7, 126.6, 125.3, 124.8, 123.9, 120.8, 117.0, 
109.3, 54.4, 40.8; IR (Neat Film, NaCl) 3155, 3062, 3029, 2927, 1950, 1805, 1698, 1601, 1585, 
1539, 1495, 1472, 1453, 1385, 1354, 1319, 1300, 1221, 1207, 1108, 1074, 911, 898, 766, 749, 
N
O
n-Pentyl
N
O
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699 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for C23H20NO [M+H]+: 326.1539, found 
326.1536. 
 
1-(1H-indol-1-yl)-4-methyl-2-phenylpentan-1-one (SI8) 
Prepared according to General Procedure 3 with i-butyl iodide (1.73 mL, 15.0 mmol, 1.5 equiv). 
Purified by column chromatography (5% Et2O in hexanes) to provide the desired product as a 
white solid (1.2177 g, 99% yield); 1H NMR (500 MHz, CDCl3) δ 8.56 (d, J = 8.3 Hz, 1H), 7.54 
(d, J = 3.8 Hz, 1H), 7.52–7.50 (m, 1H), 7.39–7.29 (m, 5H), 7.27–7.22 (m, 2H), 6.55 (dd, J = 3.8, 
0.7 Hz, 1H), 4.37 (t, J = 7.3 Hz, 1H), 2.22 (dt, J = 13.6 Hz, 7.4 Hz, 1H), 1.79 (dt, J = 13.7, 6.9 
Hz, 1H), 1.61 (dp, J = 13.5, 6.8 Hz, 1H), 0.97 (dd, J = 27.5, 6.6 Hz, 6H); 13C NMR (100 MHz, 
CDCl3) δ 172.0, 139.5, 136.1, 130.4, 129.3, 127.8, 127.5, 125.3, 124.8, 123.9, 120.9, 117.1, 
109.3, 49.8, 43.8, 25.9, 22.9, 22.7; IR (Neat Film, NaCl) 3386, 3154, 3063, 3029, 2956, 2868, 
1703, 1602, 1585 1538, 1493, 1471, 1451, 1385, 1344, 1332, 1308, 1295, 1222, 1207, 1103, 
1084, 1018, 943, 886, 766, 748, 670 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for C20H22NO 
[M+H]+: 292.1696, found 292.1696. 
 
Ligand Synthesis 
 
2-(2-bromo-5-(trifluoromethyl)phenyl)-4,5-dihydrooxazole (SI9) 
To a 500 mL round bottomed flask charged with a magnetic stirring bar and 
ethanolamine (1.35 mL, 22.31 mmol, 1.20 equiv) was added CH2Cl2 (62 mL).  To the mixture 
was added a solution of Na2CO3 (5.91 g, 55.77 mmol, 3.0 equiv) in water (46 mL).  The biphasic 
mixture is vigorously stirred at 20 ºC.  To the mixture was added 2-bromo-5-
(trifluoromethyl)benzoyl chloride2 (5.34 g, 18.59 mmol, 1.00 equiv) dropwise over 10 min.  The 
reaction mixture was vigorously stirred at 20 ºC for 14 h.  The layers were separated, and the 
aqueous layer was extracted with CH2Cl2 (4 x 50 mL).  The combined organic layers were 
N
O
NBr
O
CF3
SI9
OBr
CF3
Cl
1. Na2CO3, ethanolamine
    1.3:1 CH2Cl2/H2O, 20 ºC, 12 h
2. MsCl, Et3N, CH2Cl2
    0 to 40 ºC, 12 h
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washed with brine, dried over sodium sulfate, and concentrated to afford an amorphous white 
solid which was used in the next step without further purification.   
 To a 250 mL round bottomed flask charged with a stir bar and a reflux condenser was 
added the crude alcohol prepared above.  To the flask was added CH2Cl2 (120 mL) and Et3N (7.3 
mL, 52.2 mmol, 2.8 equiv).  The flask was cooled in a 0 ºC ice/water bath for 10 min, then MsCl 
(2.02 mL, 26.1 mmol, 1.4 equiv) was added dropwise over 2 min.  The reaction was stirred at 0 
ºC for 20 min then heated in an oil bath at 40 ºC for 8 h. The flask was then cooled to 20 ºC and 
the reaction mixture diluted with CH2Cl2 (50 mL) and transferred to a separatory funnel.  The 
organic layer was washed with water (2 x 50 mL) and brine (50 mL), then dried over Na2SO4, 
filtered, and concentrated to an orange oil.  Purification by column chromatography (15 to 25% 
EtOAc/hexanes) provided the product as a colorless oil (3.1182 g, 10.6 mmol, 57% yield); 1H 
NMR (400 MHz, CDCl3) δ 8.01 (d, J = 2.3 Hz, 1H), 7.80 (d, J = 8.3 Hz, 1H), 7.53 (dd, J = 8.4, 
2.2 Hz, 1H), 4.49 (t, J = 9.6 Hz, 2H), 4.15 (t, J = 9.6 Hz, 2H);	 13C NMR (100 MHz, CDCl3) δ 
162.7 (d, J = 3.7 Hz), 134.8, 130.5, 130.0 (q, JC–F = 35.3, 33.6 Hz), 128.3 (d, JC–F = 37.9 Hz), 
126.0, 123.7 (q, JC–F = 272.4 Hz), 68.0, 55.6; 19F NMR (282 MHz, CDCl3) δ –62.93; IR (Neat 
Film, NaCl) 2977, 1652, 1609, 1580, 1474, 1426, 1403, 1337, 1312, 1263, 1242, 1173, 1133, 
1077, 1027, 976, 947, 908, 831, 736, 712 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C10H8BrF3NO [M+H]+: 293.9736, found 293.9740. 
 
2-(2-(bis(perfluorophenyl)phosphaneyl)-5-(trifluoromethyl)phenyl)-4,5-dihydrooxazole 
(F13-glyPHOX)  
To a 100 mL Schlenk tube charged with a stir bar was added SI9 (320.5 mg, 1.09 mmol, 1.0 
equiv) and Et2O (22 mL).  The resulting solution was cooled to –78 ºC in an acetone/dry ice bath 
for 30 min, then a 1.26 M solution of sec-BuLi in hexanes (1.04 mL, 1.31 mmol, 1.2 equiv) was 
added dropwise over 5 min.  The resulting dark red solution was stirred for 30 min at –78 ºC, 
then TMEDA (200  µL, 1.32 mmol, 1.21 equiv) was added. After stirring for 15 min at –78 ºC, a 
solution of PCl(C6F5)23 (530.0 mg, 1.32 mmol, 1.21 equiv) in Et2O (11 mL) was added dropwise, 
resulting in an immediate color change to light red. After 1 h at –78 ºC, the reaction mixture was 
warmed to 0 ºC and quenched with water (10 mL). The mixture was transferred to a separatory 
CF3
(C6F5)2P N
O
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funnel and diluted with 5 mL brine before being separated. The aqueous layer was then extracted 
with Et2O (2 x 10 mL) and the combined organic layers dried over Na2SO4, filtered, and 
concentrated to yield a yellow oil. Purification by column chromatography (3% Et2O/hexanes) 
provided F13-glyPHOX as an amorphous white solid (128.7 mg, 0.222 mmol, 20% yield); 1H 
NMR (400 MHz, CDCl3) δ 8.24 (dd, J = 4.6, 1.9 Hz, 1H), 7.65 (dt, J = 8.4, 1.1 Hz, 1H), 7.36 
(dd, J = 8.4, 3.1 Hz, 1H), 4.45 (t, J = 9.6 Hz, 2H), 3.96 (t, J = 9.5 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ 162.7 (d, J = 5.7 Hz), 149.5–145.9 (m), 144.2–140.8 (m), 139.2–136.0 (m), 137.4 (d, J 
= 28.6 Hz), 133.1, 131.9 (q, J = 33.6 Hz), 131.6 (d, J = 21.7 Hz), 127.1 (d, J = 4.0 Hz), 126.4 (d, 
J = 4.1 Hz), 123.5 (q, J = 272.6 Hz), 111.5 – 109.3 (m), 68.2, 55.0; 19F NMR (282 MHz, CDCl3) 
δ –62.09 – –65.06 (m), –128.89 – –130.15 (m), –149.89 (tt, J = 20.8, 3.8 Hz), –160.33 (tt, J = 
20.8, 5.8 Hz);	 31P NMR (162 MHz, CDCl3) δ –55.11 (p, J = 36.4 Hz); IR (Neat Film, NaCl) 
1656, 1517, 1475, 1366, 1338, 1318, 1289, 1252, 1179, 1134, 1083, 1041, 977, 949 cm–1; 
HRMS (MM:ESI-APCI+) m/z calc’d for C22H8F13NOP [M+H]+: 580.0130, found 580.0138. 
 
 
 
(S)-2-(2-(bis(perfluorophenyl)phosphaneyl)-5-(trifluoromethyl)phenyl)-4-(tert-butyl)-4,5-
dihydrooxazole ((S)-F13-glyPHOX)  
To a 100 mL Schlenk tube charged with a stir bar was added (S)-2-(2-bromo-5-
(trifluoromethyl)phenyl)-4-(tert-butyl)-4,5-dihydrooxazole4 (289.2 mg, 0.826 mmol, 1.0 equiv) 
and Et2O (16.5 mL).  The resulting solution was cooled to –78 ºC in an acetone/dry ice bath for 
30 min, then a 1.26 M solution of sec-BuLi in hexanes (794 µL, 1.00 mmol, 1.2 equiv) was 
added dropwise over 5 min.  The resulting dark red solution was stirred for 30 min at –78 ºC, 
then TMEDA (150  µL, 1.00 mmol, 1.2 equiv) was added. After stirring for 15 min at –78 ºC, a 
solution of PCl(C6F5)23 (400.0 mg, 1.00 mmol, 1.2 equiv) in Et2O (8.3 mL) was added dropwise, 
resulting in an immediate color change to light red. After 1 h at –78 ºC, the reaction mixture was 
warmed to 0 ºC and quenched with water (10 mL). The mixture was transferred to a separatory 
funnel and diluted with 5 mL brine before being separated. The aqueous layer was then extracted 
CF3
(C6F5)2P N
O
Supporting Information for Fulton, Wu, Alexy, Zhang, and Stoltz 	
 
S22 
with Et2O (2 x 10 mL) and the combined organic layers dried over Na2SO4, filtered, and 
concentrated to yield a yellow oil. Purification by column chromatography (10% 
CH2Cl2/hexanes); 1H NMR (400 MHz, CDCl3) δ 8.25 (dd, J = 4.6, 1.9 Hz, 1H), 7.68 – 7.60 (m, 
1H), 7.31 (dd, J = 8.2, 3.0 Hz, 1H), 4.39 (dd, J = 10.2, 8.7 Hz, 1H), 4.22 (t, J = 8.7 Hz, 1H), 3.95 
(dd, J = 10.1, 8.7 Hz, 1H), 0.77 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 161.5 (d, J = 5.4 Hz), 
149.5 – 145.5 (m), 144.5 – 140.2 (m), 139.7 – 135.4 (m), 137.3 (d, J = 28.9 Hz), 133.0, 132.5 – 
131.3 (m), 131.9, 127.1 (q, J = 3.6 Hz), 126.4 (q, J = 4.1 Hz), 123.6 (q, J = 272.6 Hz), 111.95 – 
110.41 (m), 	 69.44, 33.63, 25.63; 19F NMR (282 MHz, CDCl3) δ –61.9 – –64.6 (m), –127.5 – –
132.1 (m), –150.3 (dtt, J = 213.8, 20.6, 3.8 Hz), –158.50 – –162.90 (m);	 31P NMR (162 MHz, 
CDCl3) δ –55.79 (p, J = 38.0 Hz); IR (Neat Film, NaCl) 2962, 1654, 1517, 1473, 1362, 1327, 
1306, 1287, 1179, 1135, 1085, 978, 834 cm–1; HRMS (MM:ESI-APCI+) m/z calc’d for 
C26H16F13NOP [M+H]+: 636.0756, found 636.0750.																																																								
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																																														 		13C	NMR	(100	MHz,	CDCl3)	of	compound	(E)-1.		
Infrared	spectrum	(Thin	Film,	NaCl)	of	compound	(E)-1.		
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Infrared	spectrum	(Thin	Film,	NaCl)	of	compound	2.		
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	 13C	NMR	(100	MHz,	CDCl3)	of	compound	3a.		
Infrared	spectrum	(Thin	Film,	NaCl)	of	compound	3a.		
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	 	13C	NMR	(100	MHz,	CDCl3)	of	compound	3b.		
Infrared	spectrum	(Thin	Film,	NaCl)	of	compound	3b.		
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	 	13C	NMR	(100	MHz,	CDCl3)	of	compound	3c.		
Infrared	spectrum	(Thin	Film,	NaCl)	of	compound	3c.		
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	 	13C	NMR	(100	MHz,	CDCl3)	of	compound	3d.		
Infrared	spectrum	(Thin	Film,	NaCl)	of	compound	3d.		
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